A Study of Autonomic Dynamic Dysfunction to Predict Infections After Spinal Cord Injury.
- Conditions
- SPINAL FractureTrauma, Spinal Cord
- Registration Number
- NCT03253952
- Lead Sponsor
- Ohio State University
- Brief Summary
The study is designed to investigate whether autonomic shifts (dysautonomia, sympatho-vagal instability) that develop after SCI have value in predicting SCI-associated infections (SCI-AI). SCI-AI impair outcomes by (1) reducing the intrinsic neurological recovery potential and (2) increasing mortality. Heart Rate Variability (HRV) data will be tracked in both the time and frequency domains to discriminate between the relative contribution of sympathetic and parasympathetic innervation to changes in HRV. The ability to predict infections will enable novel treatments thereby reducing infection-associated mortality and improving neurological and functional outcomes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 50
- Patients with acute isolated spinal cord injury (AIS A-D) planned for surgical stabilization and decompression, lesion may include more than 1 segment
- Patients with acute isolated spinal fracture, lesion may include more than 1 segment
- Legal age of the patient
- Documented informed consent of the patient
- Non-traumatic spinal cord injury
- Concomitant traumatic brain injury (TBI) (definition: i) patient with severe TBI (Glasgow Coma Scale ≤ 8) and ii) patients with intracranial pressure monitoring sensors)
- Neoplasia and/or antineoplastic therapy
- Pregnancy, lactation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sympatho-vagal instability as an identifier for patients at risk for Spinal Cord Injury Associated Infections At all study time-points for a period of 24hours. Determining whether discrete signs of loss of autonomic control (dysautonomia), not meeting defined criteria of full-autonomic dysreflexia, also renders patients "at risk" for developing infections.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
The Ohio State University Wexner Medical Center
🇺🇸Columbus, Ohio, United States
The Ohio State University Wexner Medical Center🇺🇸Columbus, Ohio, United States